Rabbit Atlastin-1 (D2E6) Monoclonal Antibody

Rabbit Atlastin-1 (D2E6) Monoclonal Antibody

Cat. No.: DAB-0011812

Size: 20 µL Size: 100 µL Size: Customer Size
Product Information
Clonality Monoclonal
Isotype IgG
Host Species Rabbit
Reactivity Human, Mouse, Rat
Applications WB
Product Description Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human atlastin-1 protein.
Format Liquid
Purity Affinity purity
Target Information
Target Name ATL1
UniProt No. Q8WXF7
Gene ID 51062
Gene Description Atlastin proteins are highly conserved members of the dynamin superfamily of membrane GTPases that are involved in the formation of vesicles for the endocytotic and secretory processes. Atlastins are required to establish and maintain the morphology of the tubular endoplasmic reticulum and are therefore important in ER function. GTP hydrolysis and dimerization are required for atlastin-dependent ER membrane fusion.Atlastin GTPase 1 is primarily expressed in brain, while the related atlastin 2 and atlastin 3 proteins are ubiquitously expressed. Mutations in the atlastin 1 gene SPG3A and the ER defects that result are thought to cause one form of hereditary spastic paraplegia, a group of heterogeneous neurological disorders characterized by severe progressive spasticity of the lower limbs.
Shipping & Storage
Shipping Shipped at 4 °C.
Storage Instructions Store at –20 °C. Do not aliquot the antibody.
Storage Buffer Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top